250 related articles for article (PubMed ID: 19069109)
1. [Clinical efficacies of antifungal injections].
Fujii Y; Inase N; Yoshizawa Y
Nihon Rinsho; 2008 Dec; 66(12):2378-83. PubMed ID: 19069109
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
[TBL] [Abstract][Full Text] [Related]
3. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin versus liposomal amphotericin B for empirical therapy.
Marty FM; Lowry CM
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675093
[No Abstract] [Full Text] [Related]
5. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Tashiro M; Izumikawa K; Minematsu A; Hirano K; Iwanaga N; Ide S; Mihara T; Hosogaya N; Takazono T; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yamamoto Y; Yanagihara K; Yasuoka A; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2012 Jan; 56(1):584-7. PubMed ID: 22024829
[TBL] [Abstract][Full Text] [Related]
7. Traditional and emerging antifungal therapies.
Arnold TM; Dotson E; Sarosi GA; Hage CA
Proc Am Thorac Soc; 2010 May; 7(3):222-8. PubMed ID: 20463252
[TBL] [Abstract][Full Text] [Related]
8. Modern antifungal therapy for neutropenic fever.
Corey M
Curr Hematol Malig Rep; 2006 Jun; 1(2):95-100. PubMed ID: 20425338
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole: review of a broad spectrum triazole antifungal agent.
Kofla G; Ruhnke M
Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
[TBL] [Abstract][Full Text] [Related]
10. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
11. A brief review of antifungal therapy for deep fungal infection.
Muller RJ
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
[TBL] [Abstract][Full Text] [Related]
12. [New development in the treatment of deep-seated mycoses].
Maesaki S
Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1993-8. PubMed ID: 17929445
[No Abstract] [Full Text] [Related]
13. [Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Garnacho-Montero J; Jiménez Parrilla F
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():33-7. PubMed ID: 21420575
[TBL] [Abstract][Full Text] [Related]
14. [Systemic antifungal agents].
Lumbreras C; Lizasoain M; Aguado JM
Enferm Infecc Microbiol Clin; 2003; 21(7):366-79; quiz 380, 390. PubMed ID: 14525693
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
16. Antifungal agents in children.
Steinbach WJ
Pediatr Clin North Am; 2005 Jun; 52(3):895-915, viii. PubMed ID: 15925667
[TBL] [Abstract][Full Text] [Related]
17. Caspofungin versus liposomal amphotericin B for empirical therapy.
Danaher PJ
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
[No Abstract] [Full Text] [Related]
18. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L
J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202
[No Abstract] [Full Text] [Related]
19. [Clinical development of antimycotics. Medical challenges].
Lipp HP
Pharm Unserer Zeit; 2003; 32(2):144-52. PubMed ID: 12677968
[No Abstract] [Full Text] [Related]
20. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
Rodríguez MM; Calvo E; Serena C; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2009 May; 53(5):2153-5. PubMed ID: 19223617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
